Influenza immunization and COVID-19

Vaccine. 2020 Sep 3;38(39):6078-6079. doi: 10.1016/j.vaccine.2020.07.058. Epub 2020 Jul 29.

Authors

Helena C Maltezou¹, Kalliopi Theodoridou², Gregory Poland³

Affiliations

¹ Directorate of Epidemiological Surveillance and Interventions for Infectious Diseases, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.
² Department of Microbiology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
³ Mayo Vaccine Research Group, Mayo Clinic and Foundation, 200 First Street, SW Rochester, MN 55905, United States.

No abstract available

Keywords: COVID-19; Healthcare personnel; High-risk patients; Immunization; Influenza; SARS-CoV-2; Vaccination.

MeSH terms

Betacoronavirus / immunology
Betacoronavirus / pathogenicity*
COVID-19
Coinfection
Coronavirus Infections / epidemiology*
Coronavirus Infections / immunology
Coronavirus Infections / virology
Europe / epidemiology
Humans
Influenza A virus / drug effects
Influenza A virus / immunology
Influenza A virus / pathogenicity
Influenza Vaccines / administration & dosage*
Influenza Vaccines / biosynthesis
Influenza, Human / epidemiology
Influenza, Human / immunology
Influenza, Human / prevention & control*
Influenza, Human / virology
Mass Vaccination / organization & administration*
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / immunology
Pneumonia, Viral / virology
SARS-CoV-2
United States / epidemiology

Substances

Influenza Vaccines